ArticleJournal of clinical medicine2023

Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV).

Jesús Troya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.